Drug Information

Drug General Information
Drug ID
D0M1RD
Former ID
DNCL002597
Drug Name
ICT-107
Drug Type
Vaccine
Indication Brain cancer; Glioblastoma multiforme [ICD9: 191, 225.0; ICD10:C71, D33] Phase 2 [523325]
Company
ImmunoCellular Therapeutics
Target and Pathway
Target(s) Interleukin-13 receptor alpha-2 chain Target Info [551019]
KEGG Pathway Jak-STAT signaling pathway
NetPath Pathway IL4 Signaling Pathway
PANTHER Pathway Interleukin signaling pathway
Pathway Interaction Database IL4-mediated signaling events
References
Ref 523325ClinicalTrials.gov (NCT01280552) A Study of ICT-107 Immunotherapy in Glioblastoma Multiforme (GBM). U.S. National Institutes of Health.
Ref 551019Clinical pipeline report, company report or official report of ImmunoCellular Therapeutics.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.